IRay therapy as an adjuvant therapy in newly diagnosed patients with neovascular age-related macular degeneration

OBJECTIVES: To determine the safety and efficacy at 12 months of follow-up after stereotactic radiotherapy in combination therapy with intravitreal ranibizumab injections in treatment naïve patients with neovascular age-related macular degeneration. METHODS: Retrospective data analysis in patients w...

Descripción completa

Detalles Bibliográficos
Autores principales: Brand, Christopher, Arnoldussen, Mark
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6085287/
https://www.ncbi.nlm.nih.gov/pubmed/29662155
http://dx.doi.org/10.1038/s41433-018-0080-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6085287/
https://www.ncbi.nlm.nih.gov/pubmed/29662155
http://dx.doi.org/10.1038/s41433-018-0080-9

Ejemplares similares